学术报告-BIOMECHANICSOFTHECORNEA:ImplicationsinGlaucomaandCornea
发布时间 :2011-01-18  阅读次数 :3093

报告题目:BIOMECHANICS OF THE CORNEA: Implications in Glaucoma and Cornea
报告人:Cynthia J. Roberts, Ph.D.
Professor, Departments of Ophthalmology and Biomedical Engineering
Martha G. and Milton Staub Chair for Research in Ophthalmology

主持单位:hbs红宝石平台 激光与光子生物医学研究所
报告地点:上海市第一人民医院眼科中心二层会议室
报告时间:2011-1-20, 星期四 下午 4:35 - 5:05


Abstract & Biography:
Idiopathic Intracranial Hypertension, Optic Nerve Sheath Fenestration, andSurgical Approaches to the Optic Nerve
Steven E. Katz, M.D.
Professor, Department of Ophthalmology, Ohio State University

Idiopathic Intracranial Hypertension (IIH) affects obese women of child-bearing age. The incidence has risen dramatically in the United States in the past two decades which may in part be related to the rise in obesity which has doubled according to the Center for Disease Control. Secondary causes of intracranial hypertension include medications (i.e., tetracycline, ciprofloxacin, exogenous growth hormone), hypervitaminosis A, venous sinus thrombosis, systemic diseases (i.e., systemic lupus erythematosis, Behcet’s disease, acromegaly) and infiltrative diseases (i.e., sarcoidosis, meningeal carcinomatosis). Astronauts appear to be a unique population at risk to develop IIH with severity proportional to length of time in orbit.
This lecture will delineate epidemiology, presenting symptoms, observed signs, neuroradiologic imaging studies, lumbar puncture, medical management, and surgical options including optic nerve sheath fenestration (ONSF) and neurosurgical shunting procedures. The goals of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) will be presented. My experience with ONSF will be used as a springboard to discuss surgical approaches to the optic nerve.

Steven E. Katz, M.D. Biography
Steven E. Katz M.D. completed his undergraduate studies at Washington University in St. Louis, Missouri in 1985. Dr. Katz attended medical school and residency in ophthalmology at Ohio State University. He then went on to do 2 years of Fellowship training: one in Orbital Disease and Oculoplastics (with Dr. Jack Rootman) and one in Neuro-ophthalmology (with Dr. Duncan Anderson) at the University of British Columbia in Vancouver, Canada. He joined the faculty at Ohio State University in the Department of Ophthalmology as an Assistant Professor in 1996 and was promoted to Associate Professor with tenure in 2002. He was awarded the Torrence A. Makley Research Professorship in Ophthalmology in 2009. His research interests include the medical and surgical management of idiopathic intracranial hypertension, management of orbital tumors, and surgical reconstruction of the orbit.
Dr. Katz has written 33 peer-reviewed journal articles and 11 book chapters. He is an article reviewer for numerous journals and a grant reviewer for the American Institute of Biological Sciences. He is a clinical and scientific advisor to the Chief of Space Medicine at NASA Johnson Space Center, and a scientific advisor to the Intracranial Hypertension Research Foundation. Dr. Katz is currently a principal investigator in the Idiopathic Intracranial Hypertension Treatment Trial which is sponsored by the National Institute of Health and the National Eye Institute.